A carregar...
Efficacy of Vedolizumab in Fistulising Crohn’s Disease: Exploratory Analyses of Data from GEMINI 2
BACKGROUND AND AIMS: Medical management of fistulising Crohn’s disease [CD] is constrained by the limited number of available therapies. We evaluated the efficacy of vedolizumab, a gut-selective α(4)β(7) integrin antagonist approved for treating moderately to severely active CD, in a subpopulation o...
Na minha lista:
| Publicado no: | J Crohns Colitis |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6018899/ https://ncbi.nlm.nih.gov/pubmed/29471381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjy019 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|